Last Price | 90.46 | Max Price | 90.75 |
Min Price | 55.90 | 1 Year return | 95.50 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Annual report 2017 |
Contact info:Street: One Boston Scientifi c PlaceZip Code: 17601537City: NatickCountry: USAPhone: 5086508000Website: www.bsci.comCEO: Michael F. MahoneyCFO: Daniel J. Brennan
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 10,735 | 2,019,579 | 0.53 % |
2020 | 9,913 | 2,170,517 | 0.46 % |
2021 | 11,888 | 2,404,876 | 0.49 % |
2022 | 12,682 | 2,645,792 | 0.48 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the last 12 months (from December 2015 till December 2016), that were profitable period for the investors in Boston Scientific, the stock gained around 18 percent. Over the period from December 2011 till December 2016 the stock rose on average 312 percent. Boston Scientific's revenues between 2011 and 2015 were quite similar and moved between 7,25 billion dollars and 7,48 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 441 million dollars and -239 million dollars.
Boston Scientific's head office is located in Natick. Boston Scientific is active in the health care eq. & services sector. Michael F. Mahoney is leading the company as CEO. The CFO of Boston Scientific the company is Daniel J. Brennan. Over the past 10 years the global health care companies gained around 102 percent. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.
The American company didn't pay out any dividends (in the past 5 years). Boston Scientific raised it's dividends per share each year in the past 5 years. Because of the yearly increased dividends Boston Scientific can be called a kind of dividend aristocrat.
Last year the balance sheet of the American company was worth 18,13 billion dollars. The total debt of the health care company was at the end of 2015 11,81 billion dollars, which equals around 65,15 percent of the total balance sheet. At the end of 2015 the health care company's stock was traded with a price/earnings-ratio 27. So the stock' value was 27 times the 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a growth stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 24,17 billion dollars. At the end of 2015 the American company had around 1,35 billion stocks listed on the stock exchange(s).
All Boston Scientific's annual reports can be found here. More information about Boston Scientific can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
7,477
|
8,386
|
9,048
|
9,823
|
10,735
|
9,913
|
Costs |
7,716
|
8,039
|
8,944
|
8,152
|
6,035
|
10,028
|
Profit |
-239
|
347
|
104
|
1,671
|
4,700
|
-115
|
Margin of profit |
-3.20
|
4.14
|
1.15
|
17.01
|
43.78
|
-1.16
|
ROI |
-3.78
|
5.15
|
1.48
|
19.15
|
33.87
|
-0.75
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
6,320
|
6,733
|
7,012
|
8,726
|
13,877
|
15,326
|
Debt |
11,813
|
11,363
|
12,030
|
12,273
|
16,688
|
15,451
|
Total assets |
18,133
|
18,096
|
19,042
|
20,999
|
30,565
|
30,777
|
Solvency |
34.85
|
37.21
|
36.82
|
41.55
|
45.40
|
49.80
|
Cash |
319
|
196
|
188
|
146
|
217
|
1,734
|
Cashflow |
691
|
1,182
|
1,426
|
309
|
1,836
|
1,508
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.06
|
0.10
|
0.12
|
0.03
|
0.11
|
0.10
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
18.44
|
21.63
|
24.79
|
35.34
|
45.22
|
Eps |
0.25
|
0.07
|
1.19
|
3.33
|
-0.08
|
Price/earnings-ratio |
73.76
|
309.00
|
20.83
|
10.61
|
-1130.75
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
4.94
|
5.11
|
6.30
|
9.95
|
10.82
|
Market to book |
0.27
|
0.24
|
0.25
|
0.28
|
0.12
|
Cashflow per stock |
0.87
|
1.04
|
0.22
|
1.32
|
1.06
|
Stocks |
1,362
|
1,373
|
1,385
|
1,395
|
1,417
|
Market Cap |
25.117.21
|
29.708.73
|
34.323.74
|
49.296.47
|
128.147.45
|
Date
|
Price
|
---|---|
17 Dec 2024
|
90.46
|
10 Dec 2024
|
88.72
|
06 Dec 2024
|
90.53
|
03 Dec 2024
|
90.43
|
29 Nov 2024
|
90.75
|
27 Nov 2024
|
90.21
|
13 Nov 2024
|
88.72
|
08 Nov 2024
|
86.88
|
05 Nov 2024
|
84.72
|
31 Oct 2024
|
83.99
|
29 Oct 2024
|
84.76
|
23 Oct 2024
|
88.01
|
19 Oct 2024
|
88.07
|
16 Oct 2024
|
86.77
|
14 Oct 2024
|
87.10
|
05 Oct 2024
|
84.54
|
02 Oct 2024
|
84.14
|
27 Sep 2024
|
83.08
|
20 Sep 2024
|
83.71
|
17 Sep 2024
|
83.51
|
13 Sep 2024
|
83.83
|
28 Aug 2024
|
79.83
|
26 Aug 2024
|
79.17
|
23 Aug 2024
|
79.58
|
11 Aug 2024
|
76.19
|
07 Aug 2024
|
73.78
|
05 Aug 2024
|
74.50
|
01 Aug 2024
|
73.88
|
30 Jul 2024
|
75.59
|
26 Jul 2024
|
74.26
|